Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3749 USD | -2.37% | -6.16% | -80.77% |
May. 15 | Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q1 Revenue $5.7M | MT |
Mar. 28 | Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
Financials (USD)
Sales 2022 | 10.88 | Sales 2023 | 19.59 | Capitalization | 4.9M |
---|---|---|---|---|---|
Net income 2022 | -25M | Net income 2023 | -14M | EV / Sales 2022 | 568,219 x |
Net cash position 2022 | 3.04M | Net cash position 2023 | 385K | EV / Sales 2023 | 230,324 x |
P/E ratio 2022 |
-0.19
x | P/E ratio 2023 |
-0.29
x | Employees | 19 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.75% |
Latest transcript on Agile Therapeutics, Inc.
1 day | -2.37% | ||
1 week | -6.16% | ||
Current month | -15.75% | ||
1 month | +1.32% | ||
3 months | -57.88% | ||
6 months | -81.80% | ||
Current year | -80.77% |
Managers | Title | Age | Since |
---|---|---|---|
Al Altomari
CEO | Chief Executive Officer | 65 | 04-01-31 |
Scott Coiante
DFI | Director of Finance/CFO | 57 | 10-11-30 |
Paul Korner
CTO | Chief Tech/Sci/R&D Officer | 58 | 20-08-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Al Altomari
CEO | Chief Executive Officer | 65 | 04-01-31 |
Seth Fischer
BRD | Director/Board Member | 68 | 16-07-27 |
John Hubbard
BRD | Director/Board Member | 67 | 14-11-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 0.3749 | -2.37% | 6,483 |
24-05-22 | 0.384 | -2.29% | 21,137 |
24-05-21 | 0.393 | +5.08% | 39,728 |
24-05-20 | 0.374 | -0.98% | 27,962 |
24-05-17 | 0.3777 | -5.47% | 20,373 |
Delayed Quote OTC Markets, May 23, 2024 at 02:36 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-80.77% | 2.57M | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-3.06% | 21.58B | |
-8.63% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- AGRX Stock